Wimmer Associates 1’s St Jude Medical STJ Stock Holding History

Wimmer Associates 1’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,250	Closed	-$341K	–	114
2016 Q4	$341K	Hold	4,250	–	–	0.32%	86
2016 Q3	$339K	Hold	4,250	–	–	0.31%	86
2016 Q2	$332K	Hold	4,250	–	–	0.3%	87
2016 Q1	$234K	Hold	4,250	–	–	0.21%	101
2015 Q4	$263K	Buy	+4,250	New	+$268K	0.28%	84

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Wimmer Associates 1's STJ Position: Q1 2017 in Review

Wimmer Associates 1 sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 4,250 shares — an estimated $341K sold.

Wimmer Associates 1 first reported a position in STJ in Q4 2015 and held it in 5 quarters. The position peaked at $341K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Wimmer Associates 1 reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Wimmer Associates 1 sold 4,250 St Jude Medical shares in Q1 2017, an estimated $341K.
Wimmer Associates 1 first reported a position in St Jude Medical in Q4 2015 and held it in 5 quarters.
Wimmer Associates 1's St Jude Medical position peaked at $341K in Q4 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Wimmer Associates 1's 13F filing for Q1 2017, filed 9 May 2017.